NeuroHarmonics

📍 London, United Kingdom🗓 Founded 2024👥 12 employees💰 Last funded Feb 2026
Biotechnology Research🌐 neuroharmonics.com
Website LinkedIn
Were developing a category defining neurotech platform that uses next-generation ultrasound technology to non-invasively treat and interface with the brain. Our approach uses precisely focused sound waves to safely modulate specific brain circuits, establishing a new paradigm for non-invasive brain-computer interaction and therapeutic intervention. Transcranial ultrasound technology shows remarkable promise, not only for treating neurological and psychiatric conditions but also as a foundation for next-generation neuromodulation applications. Our founding team combines expertise in ultrasound engineering and clinical neuroscience from world-leading institutions in medical technology and brain science. Were combining cutting-edge engineering with deep neuroscientific understanding to build what could become the gold standard for non-invasive neuromodulation, potentially transforming the lives of millions affected by brain disorders while opening new frontiers in brain-computer interaction.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Japan
1
Frequently asked questions
Who invested in NeuroHarmonics?
NeuroHarmonics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did NeuroHarmonics last raise funding?
The most recent investment in NeuroHarmonics recorded on gritt.io was in February 2026.
When was NeuroHarmonics founded?
NeuroHarmonics was founded in 2024.
What industry is NeuroHarmonics in?
NeuroHarmonics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is NeuroHarmonics based?
NeuroHarmonics is headquartered in London, United Kingdom.